Shenglan Huang
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 5
-
- Cancer, Lipids, and Metabolism 5
- Cancer-related molecular mechanisms research 3
- Cancer, Hypoxia, and Metabolism 2
-
- Cancer Immunotherapy and Biomarkers 6
-
- Cancer Mechanisms and Therapy 3
-
- Ferroptosis and cancer prognosis 9
-
- RNA modifications and cancer 4
- Cited by
- HepatologyCancer ResearchOncology
- Partner nations
- China
In The Last Decade
Shenglan Huang
20 papers receiving 291 citations
Peers
Comparison fields: 5 of 54
- Hepatology 60
- Cancer Research 95
- Oncology 69
- Pathology and Forensic Medicine 43
- Immunology 48
Countries citing papers authored by Shenglan Huang
This map shows the geographic impact of Shenglan Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenglan Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenglan Huang more than expected).
Fields of papers citing papers by Shenglan Huang
This network shows the impact of papers produced by Shenglan Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenglan Huang. The network helps show where Shenglan Huang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shenglan Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 0 | |
| 7 | 2022 | 7 | |
| 8 | 2022 | 21 | |
| 9 | 2022 | 6 | |
| 10 | 2022 | 7 | |
| 11 | 2022 | 4 | |
| 12 | 2022 | 8 | |
| 13 | 2022 | 10 | |
| 14 | 2021 | 36 | |
| 15 | 2021 | 30 | |
| 16 | 2021 | 24 | |
| 17 | 2021 | 12 | |
| 18 | 2020 | 15 | |
| 19 | 2018 | 52 | |
| 20 | 2011 | 11 |
About Shenglan Huang
Shenglan Huang is a scholar working on Cancer Research, Hepatology and Oncology, having authored 23 papers that have together received 295 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (9 papers), Cancer Immunotherapy and Biomarkers (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cancer, Lipids, and Metabolism (5 papers), RNA modifications and cancer (4 papers), Cancer Mechanisms and Therapy (3 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Hepatology (60 citations), Cancer Research (95 citations) and Oncology (69 citations). Shenglan Huang has collaborated with scholars based in China. Frequent co-authors include Jianbing Wu, Lingling Zhuang, Dan Li, Li‐Ying Sun, Mao Ye, Zhifeng Zhou, Shuping Chen, Yunbin Ye, Mingshui Chen and Wansong Lin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.